Epidemiology, clinical presentation, diagnosis and treatment of autoimmune pancreatitis: A retrospective analysis of 53 patients

Pancreatology

Volumn 16, Issue 1, 2016, Pages 73-77

  Rasch, Sebastian ^a   Phillip, Veit ^a   Schmid, Roland M ^a   Algü, Hana ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoimmune; Centric; Chronic pancreatitis; Disease; Duct; Idiopathic; IgG4; IgG4 related; Lymphoplasmacytic; Pancreatitis; Sclerosing

Indexed keywords

AZATHIOPRINE; STEROID;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; JAUNDICE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT INDICATION; TREATMENT RESPONSE; TYPE I AUTOIMMUNE PANCREATITIS; TYPE II AUTOIMMUNE PANCREATITIS; AUTOIMMUNE DISEASE; CLASSIFICATION; GERMANY; MIDDLE AGED; PANCREATITIS; YOUNG ADULT;

ADULT; AGED; AUTOIMMUNE DISEASES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84949678786     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2015.11.006     Document Type: Article

References (30)

1. Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and igg4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010;7:401-9.
2. Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in japan from a nationwide survey in 2002. J Gastroenterol 2007;42(Suppl. 18): 6-8.
3. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003;237:853-8. discussion 858-859.
4. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas 2011;40:352-8.
5. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum igg4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
6. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003;98:2811-2.
7. Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Republished: recent advances in autoimmune pancreatitis: type 1 and type 2. Postgrad Med J 2014;90:18-25.
8. Kloppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010;45:787-93.
9. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119-27.
10. Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-63.
11. Buijs J, van Heerde MJ, Rauws EA, de Buy Wenniger LJ, Hansen BE, Biermann K, et al. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis. Pancreas 2014;43:261-7.
12. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58: 1504-7.
13. Detlefsen S, Drewes AM. Autoimmune pancreatitis. Scand J Gastroenterol 2009;44:1391-407.
14. Ikeura T, Detlefsen S, Zamboni G, Manfredi R, Negrelli R, Amodio A, et al. Retrospective comparison between preoperative diagnosis by international consensus diagnostic criteria and histological diagnosis in patients with focal autoimmune pancreatitis who underwent surgery with suspicion of cancer. Pancreas 2014;43(5):698-703.
15. Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the mayo clinic experience. Gut 2013;62:1607-15.
16. Kawa S, Okazaki K, Notohara K, Watanabe M, Shimosegawa T. Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis. J Gastroenterol 2015;50(7):805-15.
17. Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreatol Off J Int Assoc Pancreatol 2010;10:664-72.
18. Rasch S, Phillip V, Weirich G, Esposito I, Gaa J, Schmid RM, et al. autoimmune pancreatitis - treatment and pitfalls in diagnostics. Der Internist 2014;55: 1231-41.
19. Fritz S, Bergmann F, Grenacher L, Sgroi M, Hinz U, Hackert T, et al. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2. Br J Surg 2014;101: 1257-65.
20. Ravi K, Chari ST, Vege SS, Sandborn WJ, Smyrk TC, Loftus Jr EV. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis 2009;15:1326-30.
21. Song TJ, Kim JH, Kim MH, Jang JW, Park do H, Lee SS, et al. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol 2012;27:700-8.
22. Charalabopoulos A, Misiakos EP, Foukas P, Tsapralis D, Charalampopoulos A, Liakakos T, et al. Localized peripancreatic plasma cell castleman disease. Am J Surg 2010;199:e51-53.
23. Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, et al. Systemic igg4-related lymphadenopathy: a clinical and pathologic comparison to multicentric castleman's disease. Mod Pathol Off J U S Can Acad Pathol Inc 2009;22:589-99.
24. Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of castleman disease. Cancer Control J Moffitt Cancer Cent 2014;21:266-78.
25. Chari ST, Murray JA. Autoimmune pancreatitis, part ii: the relapse. Gastroenterology 2008;134:625-8.
26. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin g4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-15.
27. Okazaki K, Tomiyama T, Mitsuyama T, Sumimoto K, Uchida K. Diagnosis and classification of autoimmune pancreatitis. Autoimmun Rev 2014;13:451-8.
28. Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czako L, et al. Longterm outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771-6.
29. Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut 2013;62: 1373-80.
30. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum igg4 levels and prompt clinical improvement in igg4- related systemic disease. Arthritis Rheum 2010;62:1755-62.